Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

When research gives you lemons – turning R&D failures into opportunities and success

Posted on February 19th, 2019 by in Pharma R&D

As highlighted in my colleague, Nicki Catchpole’s last post on accidental drug discovery, 90 Years of Penicillin, the landscape of R&D is littered with ‘failures’ that turned out to be vital innovations. Pharmaceutical R&D is no exception.

(more…)

Games and Events: A New Era of Coopetition in Pharma R&D

Posted on December 8th, 2018 by in Pharma R&D

Although R&D competition remains as fierce as ever, many pharmaceutical companies engage in various types of cooperation and partnership ventures to help drive innovation. The goal of coopetition — when companies cooperate on certain projects while maintaining a competitive stance — is to make drug development more efficient and effective. (more…)

How Greater Collaboration and Access to Data can Help Tackle Rare Diseases

Posted on November 1st, 2018 by in Pharma R&D

It is estimated that 30 million people in the United States alone are living with one of 7,000 rare diseases, this equates to 10% of the population. There is, however, little financial incentive for the pharmaceutical sector to develop new treatments for these diseases because of the small patient population each disease affects. (more…)

Rare Disease Drug Repurposing Datathon Launching

Posted on September 28th, 2018 by in Pharma R&D

Would you and your organization like to use your skills and expertise to help defeat rare diseases? On October 9, the Rare Disease Drug Repurposing Datathon is launching, offering data scientists a special opportunity (more…)